OpenVSafe by OpenVAERS
Search V-safe

2G7-31228-96017

3 vaccinations 9 coded responses 30 check-ins 9 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
038 / NH
Registered
2021-01-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-19
    Dose 1 — Moderna
  2. 2021-01-20
    Registered in v-safe
  3. 2021-01-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-01-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness
    Free text: Lightheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-26
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-02-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-09
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-16
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-18
    Dose 2 — Moderna
  12. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-06
    Health check-in — day 14, dose 2
    Feeling: Poor
    Adult check-in
  16. 2021-03-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-01
    Survey response — day 42, dose 2
    MedDRA: Derealisation, Dissociation, Office visit — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Dissociation/derealization · Healthcare visit (other): In office visit with psych and PCP
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-01
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-08
  23. 2021-08-22
    Survey response — 6 months, dose 2
    MedDRA: Autonomic nervous system imbalance — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Autonomic dysfunction
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-08-22
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  25. 2021-08-24
  26. 2021-11-30
    Dose 3 — Moderna
  27. 2021-12-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Brain fog, Discomfort, Ear discomfort, Head discomfort, Rash macular, Skin discolouration, Somnolence — Feeling: Poor · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Groggy/brain fog, ear fullness, head & facial pressure, EXTREMELY red & splotchy/discolored hands & feet
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-12-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  29. 2021-12-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-12-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-12-13
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-12-14
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-12-22
    Survey response — day 21, dose 3
    MedDRA: Blood bicarbonate increased, Blood glucose increased, Dizziness, Hypersomnia, Urine output decreased — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Elevated bicarbonate, low urine output, hypersomnia, lightheadedness, elevated glucose
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-12-28
    Survey response — day 28, dose 3
    MedDRA: Discomfort, Ear discomfort — Feeling: Good
    Free text: Inner ear and throat pressure
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-04
    Survey response — day 35, dose 3
    MedDRA: Autonomic nervous system imbalance, Dizziness, Erythromelalgia, Tonsillolith — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Worsening dysautonomia, worsening lightheadedness, worsening erythromelalgia, tonsil stones (all of these conditions are ongoing or recurrent)
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-11
    Survey response — day 42, dose 3
    MedDRA: Heavy menstrual bleeding, Menstruation delayed — Feeling: Fair
    Free text: Menstrual period was one day late, heavier, lasted longer, and my typical hygiene products did not fit as comfortably as they normally do
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-03-02
    Survey response — 3 months, dose 3
    MedDRA: Back pain, Blood potassium decreased, Blood pressure inadequately controlled, Heart rate abnormal, Neck pain, Oedema — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Worsening back and neck pain, uncontrollable heart rate & blood pressure, edema, low potassium
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-03-02
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  39. 2022-03-03
  40. 2022-12-04
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-19Moderna
22021-02-18Moderna
32021-11-30Moderna No

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-22

Systemic reaction (other): Lightheadedness

Release 6 — day 42, dose 2

2021-04-01

Symptoms: Dissociation/derealization
Healthcare visit (other): In office visit with psych and PCP

Release 9 — 6 months, dose 2

2021-08-22

Symptoms: Autonomic dysfunction

Release 10 — days 1–6 daily, dose 3

2021-12-01

Systemic reaction (other): Groggy/brain fog, ear fullness, head & facial pressure, EXTREMELY red & splotchy/discolored hands & feet

Release 10 — day 21, dose 3

2021-12-22

Symptoms: Elevated bicarbonate, low urine output, hypersomnia, lightheadedness, elevated glucose

Release 10 — day 28, dose 3

2021-12-28

Symptoms: Inner ear and throat pressure

Release 10 — day 35, dose 3

2022-01-04

Symptoms: Worsening dysautonomia, worsening lightheadedness, worsening erythromelalgia, tonsil stones (all of these conditions are ongoing or recurrent)

Release 10 — day 42, dose 3

2022-01-11

Symptoms: Menstrual period was one day late, heavier, lasted longer, and my typical hygiene products did not fit as comfortably as they normally do

Release 11 — 3 months, dose 3

2022-03-02

Symptoms: Worsening back and neck pain, uncontrollable heart rate & blood pressure, edema, low potassium

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDAutonomic nervous system imbalance ✓ · ✓
SDBack pain · · ✓
SDBlood bicarbonate increased · · ✓
SDBlood glucose increased · · ✓
SDBlood potassium decreased · · ✓
SDBlood pressure inadequately controlled · · ✓
SDDerealisation ✓ ✓ ✓
SDDiscomfort · · ✓
SDDissociation ✓ ✓ ✓
SDDizziness · · ✓
SDEar discomfort · · ✓
SDErythromelalgia · · ✓
SDHeart rate abnormal · · ✓
SDHeavy menstrual bleeding · · ✓
SDHypersomnia · · ✓
SDMenstruation delayed · · ✓
SDNeck pain · · ✓
SDOedema · · ✓
SDTonsillolith · · ✓
SDUrine output decreased · · ✓
SROBrain fog · · ✓
SRODiscomfort · · ✓
SRODizziness ✓ ✓ ✓
SROEar discomfort · · ✓
SROHead discomfort · · ✓
SRORash macular · · ✓
SROSkin discolouration · · ✓
SROSomnolence · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release